HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium
Published in Frontiers in Oncology, 2020
Publications
Characterization of an unbalanced translocation causing 3q28qter duplication and 10q26.2qter deletion in a patient with global developmental delay and self-injury
Published in Cold Spring Harbor Molecular Case Studies, 2020
Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of BRCA1-Mutated Human Mammary Epithelial Cells
Published in Cancers, 2020
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer
Published in NPJ Breast Cancer, 2020
Sturge-Weber syndrome patient registry: delayed diagnosis and poor seizure control
Published in Journal of Pediatrics, 2019
Measuring DNA copy number variation using high-density methylation microarrays.
Published in Journal of Computational Biology, 2019
Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer.
Published in Breast Cancer Research, 2018
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.
Published in Nature Communications, 2018
Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
Published in Oncogene, 2017
Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.
Published in Molecular Oncology, 2017
Optimizing the use of gene expression profiling in early-stage breast cancer.
Published in Journal of Clinical Oncology, 2016
HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
Published in Oncogene, 2016
Association of BRAFV600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
Published in Thyroid, 2016
Combined treatment with epigenetic, differentiating, and chemotherapeutic agents cooperatively targets tumor-initiating cells in triple negative breast cancer.
Published in Cancer Research, 2016
HOXB7 is an ERα cofactor in the activation of HER2 and multiple ER target genes leading to endocrine resistance.
Published in Cancer Discovery, 2015
Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.
Published in Breast Cancer Research, 2014
The Notch pathway inhibits TGFβ signaling in breast cancer through HEYL-mediated crosstalk.
Published in Cancer Research, 2014
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.
Published in Cancer Research, 2014
Tissue specific DNA methylation in normal human breast epithelium and in breast cancer.
Published in PLoS One, 2014
HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression.
Published in Cancer Research, 2013